UNEP Data Reporting Tool: a common house for the biodiversity family unep.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from unep.org Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
On Tuesday, May 11, 2021, an international coalition of competition enforcement agencies including the Federal Trade Commission, the U.S. Department of Justice’s Antitrust Division, Offices of State Attorneys General, Canada’s Competition Bureau, the European Commission Directorate General for Competition, and the U.K.’s Competition and Markets Authority issued a notice seeking public input to inform their approaches to analyzing the competitive effects of pharmaceutical mergers.
In March 2021, the agencies announced that they formed the Multilateral Pharmaceutical Merger Task Force (“Task Force”) to identify steps to review and update their analysis of pharmaceutical mergers. The Task Force seeks to explore “new or refreshed” theories of harm to address anticompetitive effects from pharmaceutical mergers, acquisitions, joint ventures, and consolidation. Specifically, the Task Force will review what
Multilateral Pharmaceutical Merger Task Force Seeks Public Input Details Written by FTC
Washington, DC - Staff from the Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S. Department of Justice’s Antitrust Division, and Offices of State Attorneys General has issued a notice seeking public comment to inform their review of how to best update their approaches to analyzing the effects of pharmaceutical mergers.
The agencies announced in March that they have launched a working group, now called the Multilateral Pharmaceutical Merger Task Force, to identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers. This project will ensure that FTC investigations include fresh approaches that fully analyze and address the varied competitive concerns that these mergers and acquisitions raise. It taps
FOSS Patents
Wednesday, May 12, 2021
On Wednesday (May 19, 2021), the fifth webinar of the European Commission s popular series on standard-essential patent (SEP) topics will be held. Its title is Enforcement of Standard-Essential Patents - current bottlenecks and possible solutions. In a previous post I mentioned I was going to be among the speakers.
Meanwhile, the EC s Directorate-General for the Internal Market (DG GROW) has published the agenda. After Judge Edgar Brinkman s (The Hague) welcome speech, Mary Critharis, the Chief Policy Offier and Director for International Affairs of the United States Patent & Trademark Office will deliver a keynote addressd. I m sure many of you will be as interested as I am in listening to Mrs. Critharis s speech. After a recent decision by the DOJ to downgrade an implementer-hostile policy statement by Trump s antitrust chief, many want to find out about the Biden Administration s stance on SEP enforcement. IP policy in general, and SEP pol
Health
your username
6 hours ago
On Tuesday, the Federal Trade Commission (FTC) and the U.S.
Department of Justice (DOJ) Antitrust Division announced
that a new Multilateral Pharmaceutical Merger Task Force has been created in
coordination with several international agencies. The Task Force, which was
initiated by the FTC, but also includes the Canadian Competition Bureau, the
European Commission Directorate General for Competition, the United Kingdom’s
Competition and Markets Authority, and the U.S. Offices of State Attorneys
General, is seeking the public’s help to identify steps to review and update
the process of analyzing pharmaceutical mergers.
“Public input is critical to the process of refreshing our